Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05057377 · ClinicalTrials.gov registry record
Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury
A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 16
- Enrollment target
NCT05057377 is a clinical trial that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 16 participants.
The verdict
NCT05057377 has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Traumatic brain injury (TBI) due to trauma and/or neurologic disease is a leading cause of long-term disability in the United States. The loss of balance for people with a traumatic brain injury can have a large effect on their walking abilities and this can come with a number of challenges. There is a greater risk of falling after being discharged from the hospital. In addition, people are more likely to become sedentary after TBI, which leads to the loss of muscle strength. To help provide the best care, clinicians need accurate measurements when people begin their therapy, as well as throughout to ensure they are making appropriate progress. The tests currently used by clinicians may not provide the most accurate measurements that show what a person is capable of physically doing. The study you are being asked to participate in aims to provide more accurate measurements by using a robotic treadmill device and by assessing motivating factors that are important to you. The treadmill device will allow us to more accurately test your walking ability in a safe, fall-free environment.
Interventions
- DIAGNOSTIC_TEST Standard Overground Assessment
- DIAGNOSTIC_TEST Robotic Safety-Environment Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2022-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05057377
The ClinicalTrials.gov registry entry for NCT05057377 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Overground Assessment is the first listed.
NCT05057377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05057377 about?
NCT05057377 is a clinical study titled "Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury". Traumatic brain injury (TBI) due to trauma and/or neurologic disease is a leading cause of long-term disability in the United States. The loss of balance for people with a traumatic brain injury can have a large effect on their walking abilities and this can come with a number of challenges. There i...
What is the current status of trial NCT05057377?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-09-22. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT05057377?
The interventions under investigation include: Standard Overground Assessment (DIAGNOSTIC_TEST), Robotic Safety-Environment Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05057377?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.